BMJ 2007;334:197 (27 January), doi:10.1136/bmj.39048.407928.BE (published 15 December 2006)
Research
Comparison of treatment effects between animal experiments and clinical trials: systematic review
Pablo Perel, research fellow1,
Ian Roberts, clinical coordinator CRASH 2 trial1,
Emily Sena, PhD student2,
Philipa Wheble, medical student2,
Catherine Briscoe, medical student2,
Peter Sandercock, professor of medical neurology2,
Malcolm Macleod, senior lecturer2,
Luciano E Mignini, researcher3,
Pradeep Jayaram, senior house officer4,
Khalid S Khan, professor of obstetrics-gynaecology4
1 Crash Trials Coordinating Centre, London School of Hygiene and Tropical Medicine, London WC1E 7HT,
2 Clinical Neurosciences, University of Edinburgh,
3 Centro Rosarino de Estudios Perinatales, WHO Collaborative Centre in Maternal and Child Health, Rosario 2000, Argentina,
4 Division of Reproductive and Child Health, Birmingham Women's Hospital, University of Birmingham
Correspondence to: P Perel pablo.perel{at}lshtm.ac.uk
Objective To examine concordance
between treatment effects in animal experiments and clinical
trials.
Study design Systematic review.
Data sources Medline, Embase, SIGLE, NTIS, Science Citation Index, CAB, BIOSIS.
Study selection Animal studies for interventions with unambiguous evidence of a treatment effect (benefit or harm) in clinical trials: head injury, antifibrinolytics in haemorrhage, thrombolysis in acute ischaemic stroke, tirilazad in acute ischaemic stroke, antenatal corticosteroids to prevent neonatal respiratory distress syndrome, and bisphosphonates to treat osteoporosis.
Review methods Data were extracted on study design, allocation concealment, number of randomised animals, type of model, intervention, and outcome.
Results Corticosteroids did not show any benefit in clinical trials of treatment for head injury but did show a benefit in animal models (pooled odds ratio for adverse functional outcome 0.58, 95% confidence interval 0.41 to 0.83). Antifibrinolytics reduced bleeding in clinical trials but the data were inconclusive in animal models. Thrombolysis improved outcome in patients with ischaemic stroke. In animal models, tissue plasminogen activator reduced infarct volume by 24% (95% confidence interval 20% to 28%) and improved neurobehavioural scores by 23% (17% to 29%). Tirilazad was associated with a worse outcome in patients with ischaemic stroke. In animal models, tirilazad reduced infarct volume by 29% (21% to 37%) and improved neurobehavioural scores by 48% (29% to 67%). Antenatal corticosteroids reduced respiratory distress and mortality in neonates whereas in animal models respiratory distress was reduced but the effect on mortality was inconclusive (odds ratio 4.2, 95% confidence interval 0.85 to 20.9). Bisphosphonates increased bone mineral density in patients with osteoporosis. In animal models the bisphosphonate alendronate increased bone mineral density compared with placebo by 11.0% (95% confidence interval 9.2% to 12.9%) in the combined results for the hip region. The corresponding treatment effect in the lumbar spine was 8.5% (5.8% to 11.2%) and in the combined results for the forearms (baboons only) was 1.7% (1.4% to 4.7%).
Conclusions Discordance between animal and human studies may be due to bias or to the failure of animal models to mimic clinical disease adequately.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
Evaluating the causal relevance of diverse risk markers: horizontal systematic review
- Hannah Kuper, Amanda Nicholson, Mika Kivimaki, Amina Aitsi-Selmi, Gianpiero Cavalleri, John E Deanfield, Peter Heuschmann, Xavier Jouven, Sofia Malyutina, Bongani M Mayosi, Susanna Sans, Troels Thomsen, Jacqueline C M Witteman, Aroon D Hingorani, Debbie A Lawlor, and Harry Hemingway
BMJ 2009 339: b4265.
[Abstract]
[Full Text]
[PDF]
-
A broader view of animal research
- Timothy I Musch, Robert G Carroll, Armin Just, Pascale H Lane, and William T Talman
BMJ 2007 334: 274.
[Extract]
[Full Text]
[PDF]
-
Translating animal research into clinical benefit
- Daniel G Hackam
BMJ 2007 334: 163-164.
[Extract]
[Full Text]
[PDF]
-
Where is the evidence that animal research benefits humans?
- Pandora Pound, Shah Ebrahim, Peter Sandercock, Michael B Bracken, and Ian Roberts
BMJ 2004 328: 514-517.
[Extract]
[Full Text]
[PDF]
-
Measuring inconsistency in meta-analyses
- Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, and Douglas G Altman
BMJ 2003 327: 557-560.
[Extract]
[Full Text]
[PDF]
-
Local warming does help when inserting cannulas
- Jeanette Beer
BMJ 2002 325: 1038.
[Extract]
[Full Text]
-
Does animal experimentation inform human healthcare? Observations from a systematic review of international animal experiments on fluid resuscitation
- Ian Roberts, Irene Kwan, Phillip Evans, and Steven Haig
BMJ 2002 324: 474-476.
[Extract]
[Full Text]
[PDF]
-
Bias in meta-analysis detected by a simple, graphical test
- Matthias Egger, George Davey Smith, Martin Schneider, and Christoph Minder
BMJ 1997 315: 629-634.
[Abstract]
[Full Text]
Related external webpages:
- Paper plus
This article has been cited by other articles:
-
Kuper, H., Nicholson, A., Kivimaki, M., Aitsi-Selmi, A., Cavalleri, G., Deanfield, J. E, Heuschmann, P., Jouven, X., Malyutina, S., Mayosi, B. M, Sans, S., Thomsen, T., Witteman, J. C M, Hingorani, A. D, Lawlor, D. A, Hemingway, H.
(2009). Evaluating the causal relevance of diverse risk markers: horizontal systematic review. BMJ
339: b4265-b4265
[Abstract]
[Full text]
-
Bracken, M. B
(2009). Why animal studies are often poor predictors of human reactions to exposure. JRSM
102: 120-122
[Full text]
-
Nasser, M., Tibi, A., Savage-Smith, E.
(2009). Ibn Sina's Canon of Medicine: 11th century rules for assessing the effects of drugs. JRSM
102: 78-80
[Full text]
-
Macleod, M. R., van der Worp, H. B., Sena, E. S., Howells, D. W., Dirnagl, U., Donnan, G. A.
(2008). Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality. Stroke
39: 2824-2829
[Abstract]
[Full text]
-
El-Hakim, H., Richards, S., Thevasagayam, M. S.
(2008). Major Salivary Duct Clipping for Control Problems in Developmentally Challenged Children. Arch Otolaryngol Head Neck Surg
134: 470-474
[Abstract]
[Full text]
-
Crossley, N. A., Sena, E., Goehler, J., Horn, J., van der Worp, B., Bath, P. M.W., Macleod, M., Dirnagl, U.
(2008). Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach. Stroke
39: 929-934
[Abstract]
[Full text]
-
Belmaker, R.H., Agam, G.
(2008). Major Depressive Disorder. NEJM
358: 55-68
[Full text]
-
HAFIZI, S., CHANDRA, P., COWEN, J.
(2007). Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations. Br. J. Psychiatry
191: 282-284
[Abstract]
[Full text]
-
Talbot, K.
(2007). The study of rare diseases: butterfly collecting or an entree to understanding common conditions?. PN
7: 210-211
[Full text]
-
Milbrandt, E. B., Ishizaka, A., Angus, D. C.
(2007). Update in Critical Care 2006. Am. J. Respir. Crit. Care Med.
175: 638-648
[Full text]
-
Musch, T. I, Carroll, R. G, Just, A., Lane, P. H, Talman, W. T
(2007). A broader view of animal research. BMJ
334: 274-274
[Full text]
-
Hackam, D. G
(2007). Translating animal research into clinical benefit. BMJ
334: 163-164
[Full text]
Rapid Responses:
Read all Rapid Responses
- On “concordance” and “discordance”
- Marco Mamone-Capria
bmj.com, 10 Jan 2007
[Full text]
- Medical Progress: thanks to clinical research, not animal research
- Kathy A Archibald
bmj.com, 23 Jan 2007
[Full text]
- The failure of animal research
- Marlene A. Thompson
bmj.com, 30 Jan 2007
[Full text]
- A Broader View of Animal Research
- Timothy I. Musch, et al.
bmj.com, 31 Jan 2007
[Full text]
- Animal models of human disease; of mice and menace
- Janusz A Jankowski, et al.
bmj.com, 31 Jan 2007
[Full text]
- An uncited paper
- Neville W Goodman
bmj.com, 7 Feb 2007
[Full text]